+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Anti-Obesity Therapeutics Market by Treatment Type, End-use - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-Obesity Therapeutics Market by Treatment Type, End-use - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End-use (Patients, Providers, Payers), By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End-use (Patients, Providers, Payers), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • April 2024
  • 130 Pages
  • Global
From
Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 110 Pages
  • Global
From
Liraglutide Market Report 2024 - Product Thumbnail Image

Liraglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Orlistat Market Report 2024 - Product Thumbnail Image

Orlistat Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Liraglutide and Semaglutide Market Report 2024 - Product Thumbnail Image

Liraglutide and Semaglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Antiobesity Global Market Report 2024 - Product Thumbnail Image

Antiobesity Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 184 Pages
  • Global
From
Growth Opportunities in Obesity Drugs and Delivery Platforms - Product Thumbnail Image

Growth Opportunities in Obesity Drugs and Delivery Platforms

  • Report
  • December 2023
  • 51 Pages
  • Global
From
Noninvasive Fat Reduction Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, End User, and Geography - Product Thumbnail Image

Noninvasive Fat Reduction Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology, End User, and Geography

  • Report
  • April 2024
  • 145 Pages
  • Global
From
Non-invasive Fat Reduction Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Non-invasive Fat Reduction Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 188 Pages
  • Global
From
Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Global
From
Pro-Opiomelanocortin (POMC) Deficiency Obesity & Leptin Receptor (LEPR) Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pro-Opiomelanocortin (POMC) Deficiency Obesity & Leptin Receptor (LEPR) Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hypothalamic Obesity (HO) - Pipeline Insight, 2024 - Product Thumbnail Image

Hypothalamic Obesity (HO) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Product Thumbnail Image

Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Fat Metaboliser Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Thumbnail Image

Fat Metaboliser Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • January 2024
  • 85 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more